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Metabolic responses to prolonged consumption of glucose- and
fructose-sweetened beverages are not associated with postprandial
or 24-h glucose and insulin excursions1–3
Kimber L Stanhope, Steven C Griffen, Andrew A Bremer, Roel G Vink, Ernst J Schaefer, Katsuyuki Nakajima,
Jean-Marc Schwarz, Carine Beysen, Lars Berglund, Nancy L Keim, and Peter J Havel
ABSTRACT
Background: Consumption of sugar-sweetened beverages has been
shown to be associated with dyslipidemia, insulin resistance, fatty
liver, diabetes, and cardiovascular disease. It has been proposed
that adverse metabolic effects of chronic consumption of sugar-
sweetened beverages are a consequence of increased circulating
glucose and insulin excursions, ie, dietary glycemic index (GI).
Objective: We determined whether the greater adverse effects of
fructose than of glucose consumption were associated with glucose
and insulin exposures.
Design: The subjects were studied in a metabolic facility and con-
sumed energy-balanced diets containing 55% of energy as complex
carbohydrate for 2 wk (GI = 64). The subjects then consumed 25%
of energy requirements as fructose- or glucose-sweetened beverages
along with their usual ad libitum diets for 8 wk at home and then
as part of energy-balanced diets for 2 wk at the metabolic facility
(fructose GI = 38, glucose GI = 83). The 24-h glucose and
insulin profiles and fasting plasma glycated albumin and fructos-
amine concentrations were measured 0, 2, 8, and 10 wk after bev-
erage consumption.
Results: Consumption of fructose-sweetened beverages lowered
glucose and insulin postmeal peaks and the 23-h area under the
curve compared with the baseline diet and with the consumption
of glucose-sweetened beverages (all P , 0.001, effect of sugar).
Plasma glycated albumin concentrations were lower 10 wk after
fructose than after glucose consumption (P , 0.01, effect of sugar),
whereas fructosamine concentrations did not differ between groups.
Conclusion: The results suggest that the specific effects of fructose,
but not of glucose and insulin excursions, contribute to the adverse
effects of consuming sugar-sweetened beverages on lipids and
insulin sensitivity. This study is registered at clinicaltrials.gov as
NCT01165853. Am J Clin Nutr 2011;94:112–9.
INTRODUCTION
Consumption of sugar-sweetened beverages has been shown
in epidemiologic studies to be associated with the development
of dyslipidemia (1, 2), insulin resistance (3, 4), fatty liver (5, 6),
type 2 diabetes (7–9), and cardiovascular disease (10, 11). We
conducted a dietary intervention study during which older,
overweight or obese men and women consumed either fructose-
or glucose-sweetened beverages providing 25% of energy re-
quirements for 10 wk. We reported that de novo lipogenesis, 23-h
area under the curves (AUCs) for circulating triglycerides, and
concentrations of fasting apolipoprotein B, LDL, small dense
LDL, oxidized LDL, and postprandial remnant lipoprotein-
triglycerides and cholesterol increased in the subjects who con-
sumed fructose. In addition, visceral adipose deposition increased
and insulin sensitivity decreased in these subjects. None of these
adverse effects were observed in a group of subjects consuming
glucose at 25% of the energy requirement, who gained the same
amount of weight as the subjects consuming fructose (’1.4 kg)
(12). We have proposed that these adverse effects of fructose
consumption are explained by its hepatic metabolism being in-
dependent of energy status, which leads to unregulated hepatic
fructose uptake and increased lipogenesis (12–15). The resulting
increase in the hepatic lipid supply leads to increased production
and secretion of VLDL and is associated with decreased hepatic
insulin sensitivity. Because the commonly consumed sugars su-
crose and high-fructose corn syrup (HFCS) are composed of 50%
to 55% fructose, these proposed mechanisms may explain the
associations between sugar consumption and metabolic disease
(1–11). However, it has also been suggested that the adverse ef-
fects associated with chronic consumption of sugar-sweetened
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beverages result from increased circulating glucose and insulin
excursions [ie, glycemic index (GI)] (16–19). Mechanisms by
which increased circulating glucose and insulin excursions are
proposed to mediate the adverse effects associated with an in-
creased risk of type 2 diabetes and cardiovascular disease have
been reviewed (20) and include redistribution of metabolic sub-
strates to adipose tissue; insulin resistance mediated by the direct
effects of hyperglycemia, counterregulatory hormone secretion,
and increased levels of postprandial free fatty acids; glucotox-
icity; lipotoxicity; hyperglycemia-induced oxidative stress; and
independent effects of hyperinsulinemia on blood pressure, lipids,
inflammatory mediators and endothelial function.
The objective of this study was to investigate the relation
between meal-induced glucose and insulin excursions and overall
glucose exposure with the metabolic effects observed in subjects
consuming glucose- and fructose-sweetened beverages (12).
Therefore, we measured the 24-h profiles of glucose and insulin
and fasting plasma concentrations of glycated albumin and
fructosamine in samples collected during our previously reported
study from the same subjects who consumed glucose- or fructose-
sweetened beverages for 10 wk (12).
SUBJECTS AND METHODS
The participants were recruited through newspaper adver-
tisements and underwent a complete blood count, a serum bio-
chemistry panel, and a telephone and an in-person interview to
obtain a medical history to assess eligibility. Inclusion criteria
included age 40–72 y and a body mass index (BMI; in kg/m2) of
25–35 with a self-report of stable body weight during the prior
6 mo. Women were postmenopausal based on a self-report of no
menstruation for 1 y. Exclusion criteria included diabetes (fast-
ing glucose .125 mg/dL), renal or hepatic disease, fasting serum
triglyceride concentrations .400 mg/dL, hypertension (.140/90
mm Hg), and surgery for weight loss. Individuals who smoked,
reported exercise of .3.5 h/wk at a level more vigorous than
walking, or used thyroid, lipid-lowering, glucose-lowering, anti-
hypertensive, antidepressant, or weight-loss medications were also
excluded. Diet-related exclusion criteria included habitual in-
gestion of more than one sugar-sweetened beverage daily or .2
alcoholic beverages/d. The University of California, Davis, In-
stitutional Review Board approved the experimental protocol, and
subjects provided informed consent to participate in the study.
Thirty-nine subjects enrolled in the study and experimental groups
were matched for sex, BMI, and fasting triglyceride and insulin
concentrations. Subjects and University of California, Davis,
Clinical and Translational Science Center’s Clinical Research
Center (CCRC) and technical personnel were blinded to the sugar
assignments. Seven subjects (3 in the glucose group, 4 in the
fructose group) did not complete the study because of an inability
or unwillingness to comply with the protocol or because of per-
sonal or work-related conflicts. Seventeen subjects consuming
fructose-sweetened beverages and 15 subjects consuming glucose-
sweetened beverages completed the study, and the previously re-
ported (12) lipid, adiposity, and insulin sensitivity results from this
study were obtained from these same subjects.
As previously described (12), this was a parallel-arm, diet
intervention study that consisted of 3 phases: 1) a 2-wk inpatient
baseline period during which subjects consumed an energy-
balanced diet, 2) an 8-wk outpatient intervention period during
which subjects consumed glucose- (n = 15) or fructose-sweet-
ened (n = 17) beverages providing 25% of daily energy re-
quirements along with their usual ad libitum diet, and 3) a 2-wk
inpatient intervention period during which subjects consumed
25% of daily energy requirements as their assigned sugar-sweetened
beverage along with an energy-balanced diet. During the 2-wk
baseline and intervention inpatient periods of the study, subjects
resided in the CCRC and consumed energy-balanced [based on
the Mifflin equation (21)] meals consisting of conventional foods.
The baseline diet contained 55% of energy as mainly complex
carbohydrate, 30% as fat, and 15% as protein and had a calculated
GI of 64. The intervention inpatient meals were as identical as
possible to those served during baseline, except that the carbohy-
drate was provided as 25% of energy as glucose- or fructose-
sweetened beverages and 30% of energy as complex carbohydrate.
The GIs of the glucose- and fructose-containing diets were 83 and
38, respectively. The timing of meal service and the energy distri-
bution were as follows: breakfast (0900, 25%), lunch (1300, 35%),
and dinner (1800, 40%). Sugars were provided to the subjects as 3
daily servings of glucose- or fructose-sweetened beverages flavored
with an unsweetened drink mix (Kool-Aid; Kraft, Northfield, IL).
During the 8-wk outpatient phase of the study, the subjects were
instructed to drink 3 servings of sugar-sweetened beverages/d (one
with each meal), to consume their usual diet, and to not consume
other sugar-containing beverages, including fruit juice. The sugar-
sweetened beverages contained a biomarker (riboflavin), which was
measured fluorimetrically in urine samples collected at the time of
beverage pickup to monitor compliance. These measurements in-
dicated that the 2 groups of subjects were comparably compliant
(12).
Estimates of food intake during the outpatient phase of the
study were collected by 24-h recall (via telephone) with the use of
the US Department of Agriculture’s 5-step multiple pass method
as described by Conway et al (22). The recalls were conducted on
3 random days per week before the study began and during
intervention weeks 2 and 7. The same registered dietitian ad-
ministered the recall to all subjects. The recalls were analyzed
with Nutrition Data System for Research (version 2005; Minne-
apolis, MN). The results from all 3 prestudy recalls were averaged,
as were the results from the 6 intervention recalls, except for
reports that were judged by the dietitian to be outliers to the usual
dietary pattern because of illness or other circumstances.
Twenty-four-hour serial blood collections were conducted
during baseline (0 wk) and at 2, 8, and 10 wk of the intervention.
The meals served were identical at all 3 intervention time points
(2, 8, and 10 wk), and the intervention meals were matched as
closely as possible to the baseline meals (0 wk), except for the
substitution of 25% of energy from sugars in the sugar-sweetened
beverages for the complex carbohydrate. The 24-h blood col-
lections at baseline (0 wk) and at the end of the intervention
(10 wk) were performed after subjects had consumed energy-
balanced, weight-maintaining diets in the CCRC for 10 d. The
24-h blood collections performed after 2 and 8 wk of intervention
were preceded by 2- and 8-wk periods of ad libitum food intake.
The 24-h profile data were not obtained from one subject from the
glucose group because of failure of the catheter to remain patent
during the baseline trial.
On the days of serial blood sampling, an intravenous catheter
was inserted into an arm vein by a registered nurse at 0730 and
kept patent with a slow saline infusion. Three fasting blood
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samples were collected into tubes containing EDTA at 0800,
0830, and 0900. Thirty-three postprandial blood samples were
collected at 30–60-min intervals from 0930 to 0800 the next
morning (23, 24). An additional 3–6 mL blood was collected at
the 3 fasting time points; this plasma was pooled and stored as
multiple aliquots at 270C.
Glucose concentrations were measured with an automated
glucose analyzer (YSI Inc, Yellow Springs, OH) and insulin by
radioimmunoassay (Millipore, St Charles, MO). The pooled
fasting plasma samples were analyzed enzymatically (25) in the
laboratory of Ernst Schaefer for glycated albumin and for
fructosamine concentrations by using a Polychem Chemistry
Analyzer (PolyMedCo Inc, Cortland Manor, NY).
The incremental 23-hAUCwas calculated for glucose and insulin
by using the trapezoidal method. The mean concentration of the 3
fasting samples was determined, and the net AUCwas calculated by
subtracting the AUC values below fasting from the AUC values
above fasting levels. Glucose and insulin responses were also
assessed by the mean amplitudes of the 3 postmeal peaks. Spe-
cifically, the peak postmeal value minus the premeal value was
averaged for breakfast, lunch, and dinner for each subject. Statistical
tests were performed with SAS 9.2 in a repeated-measure (RM)
mixed procedures (PROCMIXED; SAS Institute, Cary, NC) model
with time, sugar, sex, and number ofmetabolic syndrome risk factors
(MSRFs) as factors. Insignificant 3-factor interactions were removed
if they decreased the precision of the model. MSRFs were those
defined by the American Heart Association/National Heart Lung
and Blood Institute (26, 27). Outcomes with significant effects of
sugar · time were further analyzed in sugar-specific RM models
with time and sex as factors. Tukey’s multiple comparison post hoc
tests were used to compare values at 0 wk with the responses at 2,
8, and 10 wk. The mean GI and glycemic load (GL) of the in-
tervention 24-h food intake recalls (6/subject) were compared
with the GI and GL of the prestudy 24-h food intake recalls (3/
subject) by Student’s t test. The data are presented as means 6
SEMs.
RESULTS
As previously reported, no significant differences in any of the
baseline variables measured were observed between the 2 groups
of subjects (12). The 32 subjects were aged 53.7 6 1.4 y (range:
43–70 y) and had a BMI of 29.3 6 0.5 (range: 25.0–34.4). The
men had 27.3 6 1.3% body fat (range: 12.6–32.3%), and the
women had 41.7 6 1.1% body fat (range: 31.0–47.2%) (12).
The macronutrient composition and the GI and GL of the in-
patient diet served during the 24-h blood sampling period are
shown in Table 1. The macronutrient composition and the GI
and GL of the diets consumed by the subjects during the pre-
study week and during the outpatient intervention were esti-
mated from 24-h food intake recalls (Table 2). The GI (P ,
0.0001) and GL (P , 0.0001) of the outpatient diet increased
significantly during the intervention in the subjects who con-
sumed glucose. In the subjects who consumed fructose, the GI
(P, 0.0001) and GL (P, 0.05) of the outpatient diet decreased
significantly during the intervention. We previously reported that
during the 8-wk outpatient period, when subjects consumed their
usual ad libitum diet along with the sugar-sweetened beverages,
no significant sugar- or sex-group differences in fat, sugar, or
alcohol intake as a percentage of energy intake or in the amount
of energy consumed relative to calculated energy requirements
were observed, and both groups of subjects gained comparable
amounts of weight, ’1.4 kg (12).
The 24-h profiles of glucose and insulin at baseline during the
consumption of the complex carbohydrate diet and at 10 wk
during consumption of 25% of energy requirements as glucose-
or fructose-sweetened beverages are shown in Figure 1. The
effects of glucose and fructose consumption on the mean am-
plitude of the postmeal peaks and 23-h AUCs of circulating
glucose and insulin (Table 3) were markedly different (effect of
sugar · time: P , 0.001, 4-factor RM PROC MIXED) and were
not affected by sex or MSRF (sex · time, MSRF · time: P .
0.05 for all variables, 4-factor RM PROC MIXED). Compared
with the consumption of complex carbohydrate at 0 wk, con-
sumption of fructose lowered mean postmeal glucose (232% to
247%; effect of time: P, 0.0001, 2-factor RM PROC MIXED)
and insulin peaks (230% to 237%; P , 0.01, effect of time,
2-factor RM PROC MIXED) and consumption of glucose re-
sulted in increased mean postmeal glucose peaks (+61% to
+75%; effect of time: P , 0.001, 2-factor RM PROC MIXED).
The increases in mean postmeal insulin peaks induced by
TABLE 1
Inpatient diet composition1
Glucose Fructose
Diet components Baseline Intervention Baseline Intervention
Energy (kcal) 2390 6 762 2390 6 76 2398 6 98 2398 6 98
Protein (g) 90 6 3 90 6 3 91 6 4 90 6 4
Total fat (g) 80 6 3 80 6 3 80 6 3 80 6 3
Available carbohydrate (g) 329 6 10 329 6 10 330 6 13 330 6 13
Complex carbohydrate (g) 297 6 9 146 6 5 298 6 12 146 6 5
Experimental beverage sugar (g) 0 157 6 5 0 158 6 7
Other added sugar (g) 16 6 3 12 6 2 17 6 3 13 6 2
Total fiber (g) 21 6 3 16 6 1 21 6 3 16 6 1
Glycemic index3 64 83 64 38
Glycemic load3 200 6 6 263 6 8 200 6 8 126 6 5
1 Calculations were based on the diet consumed during the 24-h serial blood sampling period.
2 Mean 6 SEM (all such values).
3 Calculations were based on the glucose standard.
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glucose consumption (+40% to +49%; effect of time: P , 0.01,
2-factor RM PROC MIXED) were significant at 2 wk. Similarly,
compared with the consumption of complex carbohydrate,
consumption of fructose lowered 23-h glucose (259% to 280%;
effect of time: P , 0.0001, 2-factor RM PROC MIXED) and
insulin (227% to 237%; effect of time: P , 0.01, 2-factor RM
PROCMIXED) AUCs, and consumption of glucose increased 23-
h insulin AUC (+31% to +46%; effect of time: P, 0.01, 2-factor
RM PROC MIXED).
The effects of glucose and fructose consumption on risk factors
for metabolic disease that have been shown to be positively
affected by low-GI diets are shown in Table 4 (28). As pre-
viously reported, fasting glucose concentrations were signifi-
cantly greater in the subjects who consumed fructose than in
those who consumed glucose (12). The effects of the 2 sugars
on fasting insulin concentrations were not significantly different
(12). We also previously reported that insulin sensitivity, as
assessed with the glucose disposal test (29), decreased in sub-
jects consuming fructose (217%) and was unchanged in sub-
jects consuming glucose (12). Glycated albumin values were
differentially affected by the 2 sugars (Table 4; effect of sugar ·
time: P , 0.01, 4-factor RM PROC MIXED), with fructose
tending to decrease levels (23.36 1.3%; P = 0.14, Tukey’s test)
and glucose tending to increase levels (+2.1 6 1.3%; P = 0.38,
TABLE 2
Outpatient diet composition1
Glucose Fructose
Diet components Baseline Intervention Baseline Intervention
Energy (kcal) 1891 6 153 2602 6 148 2066 6 181 2534 6 156
Protein (g) 73 6 6 88 6 6 81 6 6 85 6 6
Total fat (g) 67 6 7 89 6 7 78 6 10 80 6 7
Available carbohydrate (g) 235 6 22 342 6 23 239 6 17 355 6 20
Complex carbohydrate (g) 112 6 11 111 6 10 105 6 12 115 6 10
Experimental beverage sugar (g) 0 157 6 5 0 158 6 7
Other added sugar (g) 81 6 19 56 6 10 107 6 12 64 6 11
Total fiber (g) 22 6 3 18 6 2 19 6 2 19 6 2
Glycemic index2 59 6 1 81 6 13 60 6 2 45 6 13
Glycemic load2 167 6 21 304 6 173 160 6 9 157 6 114
1 All values are means 6 SEMs. The composition of the ad libitum diet consumed during the outpatient periods was
estimated from 24-h food recall interviews.
2 Calculations were based on the glucose standard.
3,4 Significantly different from baseline (Student’s t test): 3P , 0.0001, 4P , 0.05.
FIGURE 1. Mean (6SEM) 24-h circulating glucose (A and B) and insulin (C and D) concentrations in subjects before and after consumption of glucose-
sweetened (n = 14) or fructose-sweetened (n = 17) beverages for 10 wk.
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Tukey’s test) at 10 wk compared with baseline. No effects of
fructose or glucose consumption on plasma fructosamine con-
centrations were observed.
DISCUSSION
We proposed that the dyslipidemia and decreased insulin
sensitivity observed in subjects who consume fructose-sweetened
beverages for 10 wk at 25% of energy requirements (12) are
explained by the hepatic metabolism of fructose being in-
dependent of energy status, which leads to unregulated hepatic
fructose uptake and lipogenesis, increased hepatic lipid and
production/secretion of VLDLs, and decreased hepatic insulin
sensitivity (14, 15). However, it has also been proposed that the
adverse effects of chronic consumption of sugar-sweetened
beverages (1–11) result from increased circulating glucose and
insulin excursions, ie, GI (16–19). We investigated this by
measuring the 24-h profiles of glucose and insulin and fasting
plasma concentrations of glycated albumin and fructosamine in
the same subjects who consumed glucose- or fructose sweetened
beverages for 10 wk. The new results reported here indicate that
glucose and insulin excursions and exposure are substantially
TABLE 3
Indexes of glucose and insulin exposure before and 2, 8, and 10 wk after consumption of glucose-sweetened (n = 14) or fructose-sweetened (n = 17)
beverages1
Variable and preceding diet
Complex carbohydrates,
0 wk (energy balance)
Sugar, 2 wk
(ad libitum)
Sugar, 8 wk
(ad libitum)
Sugar, 10 wk
(energy balance)
P value
(sugar · time)2
Postmeal glucose peaks (mg/dL)
Glucose (n = 14) 45.1 6 3.9 72.5 6 8.13 73.0 6 6.83 78.3 6 7.54 ,0.0001
Fructose (n = 17) 48.2 6 4.3 24.2 6 2.63 28.8 6 2.63 33.0 6 3.63
23-h Glucose AUC (mg/dL  23 h)
Glucose (n = 14) 254.3 6 20.1 247.4 6 47.2 253.9 6 43.7 342.4 6 41.7 ,0.001
Fructose (n = 17) 308.1 6 34.1 45.9 6 22.55 100.3 6 29.54 125.6 6 29.84
Postmeal insulin peaks (lU/mL)
Glucose (n = 14) 94.7 6 20.5 127.3 6 24.46 119.3 6 15.4 136.2 6 36.3 ,0.0001
Fructose (n = 17) 97.6 6 15.7 60.0 6 8.63 66.1 6 10.73 64.0 6 8.26
23-h Insulin AUC (lU/mL  23 h)
Glucose (n = 14) 596.1 6 118.7 699.6 6 117.6 693.0 6 118.7 757.5 6 138.53 ,0.0001
Fructose (n = 17) 681.4 6 112.6 426.1 6 66.63 489.1 6 85.83 480.4 6 72.93
1 All values are means 6 SEMs. AUC, area under the curve.
2 PROC MIXED (SAS Institute, Cary, NC) 4-factor (sugar, time, sex, and metabolic syndrome risk factors) repeated-measures analysis.
3–6 Significantly different from 0 wk [PROC MIXED 2-factor (time, sex) repeated-measures analysis, Tukey’s multiple comparison tests]: 3P , 0.01,
4P , 0.001, 5P , 0.0001, 6P , 0.05.
TABLE 4
Fasting plasma glucose, insulin, glycated albumin, and fructosamine concentrations and insulin sensitivity before and 2, 8, and 10 wk after consumption of
glucose- or fructose-sweetened beverages1
Variable and preceding diet
Complex carbohydrates,
0 wk (energy balance)
Sugar, 2 wk
(ad libitum)
Sugar, 8 wk
(ad libitum)
Sugar, 10 wk
(energy balance)
P value
(sugar · time)
Fasting glucose (mg/dL)2
Glucose (n = 15) 87.6 6 1.5 88.0 6 1.9 89.8 6 2.1 86.4 6 1.3 ,0.00013
Fructose (n = 17) 88.7 6 1.0 95.7 6 2.14 94.6 6 2.14 93.6 6 1.35
Fasting insulin (lU/mL)2
Glucose (n = 15) 15.0 6 1.9 15.8 6 1.6 16.4 6 1.9 15.0 6 1.6 NS3
Fructose (n = 17) 14.0 6 1.5 17.1 6 2.0 16.3 6 2.1 15.4 6 1.7
Insulin sensitivity index (mmol 2H2O/insulin AUC)
2
Glucose (n = 14) 0.236 6 0.036 0.210 6 0.021 ,0.056
Fructose (n = 17) 0.254 6 0.049 0.208 6 0.0407
Glycated albumin (%)
Glucose (n = 15) 13.9 6 0.3 14.2 6 0.3 14.1 6 0.3 14.2 6 0.4 ,0.013
Fructose (n = 17) 14.2 6 0.3 14.1 6 0.4 14.3 6 0.3 13.8 6 0.3
Fructosamine (lmol/L)
Glucose (n = 15) 211.6 6 10.9 209.9 6 13.4 204.7 6 7.0 211.9 6 9.4 NS3
Fructose (n = 17) 219.1 6 7.1 202.3 6 6.1 204.0 6 8.4 208.8 6 8.9
1 All values are means 6 SEMs. AUC, area under the curve.
2 Results previously reported in reference 12. Insulin AUC is calculated as lU/mL · 4 h.
3 PROC MIXED (SAS Institute, Cary, NC) 4-factor (sugar, time, sex, and metabolic syndrome risk factors) repeated-measures analysis.
4,5 Significantly different from 0 wk [PROC MIXED 2-factor (time, sex) repeated-measures analysis, Tukey’s multiple comparison tests]: 4P , 0.01,
5P , 0.0001.
6 General linear model 3-factor (sugar, sex, metabolic syndrome risk factors) ANOVA on percentage difference, 10 compared with 0 wk.
7 Significantly different from 0 wk, P , 0.01 (paired t test).
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decreased in subjects who consume fructose and significantly
increased in subjects who consume glucose. Together with our
previous report that the consumption of fructose produced many
adverse metabolic effects compared with the consumption of
glucose in these same subjects (12), these results do not support
the hypothesis that increased circulating glucose and insulin
excursions either mediate or contribute to the adverse effects of
sugar-sweetened beverage consumption for 10-wk.
Furthermore, and in direct contrast with the hypothesis that
meal-induced glucose and insulin excursions promote the de-
velopment of metabolic disease, we proposed that the lowered
meal-related glucose and insulin responses in subjects consuming
fructose may contribute to the adverse effects initiated by the
unregulated hepatic metabolism of fructose (12). Insulin in-
creases lipoprotein lipase (LPL) expression and activity, and we
reported that subjects who consumed fructose had a lower post-
prandial LPL activity than did subjects who consumed glucose
(12). The lowered postprandial LPL activity likely delays post-
prandial triglyceride clearance and thus contributes to the marked
increases in postprandial triglyceride concentrations observed in
subjects consuming fructose (12). Much evidence suggests that
high concentrations of postprandial triglycerides, resulting from
either overproduction or delayed clearance, then initiate the se-
quence of lipoprotein changes that result in increased production of
remnant lipoproteins and small dense LDL particles (30–32). In
addition, we have also hypothesized that lowered postprandial LPL
activity, in response to reduced postmeal insulin peaks in subjects
consuming fructose, may lead to preferential deposition of fat in
the visceral adipose tissue. LPL in subcutaneous adipose tissue is
more responsive to the effects of insulin than is LPL in visceral
adipose tissue (33). Therefore, increased insulin responses after
consumption of glucose-sweetened beverages withmeals may lead
to greater LPL activity in subcutaneous adipose tissue and in-
creased triglyceride uptake by subcutaneous adipose tissue.
Conversely, decreased insulin responses to fructose consumption
may lead to decreased insulin-mediated LPL activity in sub-
cutaneous adipose tissue, which allows for greater triglyceride
uptake by visceral adipose tissue (12, 15).
These results have important implications regarding the effects
of dietary GI on the development of metabolic disease. GI is used
to categorize carbohydrate-containing foods based on incremental
AUCs for the glucose response after consumption of a standard
amount of carbohydrate from a test food relative to that of a control
food (glucose or white bread) (34). A low-GI diet can help to
improve glycemic control in patients with diabetes (35), and
clinical studies have shown a strong correlation between glycated
hemoglobin concentrations and vascular complications of diabetes
(36). In nondiabetic subjects, many studies suggest that high-GI
diets promote metabolic disease relative to low-GI diets (28, 37).
However, a substantial number of reports indicate that high-GI
diets are not associated with an increase in risk factors for the
development of cardiovascular disease (38), insulin resistance (39),
or type 2 diabetes (40, 41). Furthermore, a recent study showed that
consumption of diets enriched with test foods with comparable
macronutrient and fiber compositions, but with different GLs and
GIs, did not change markers for the metabolic syndrome (42). The
results of the current study indicate that known risk factors
of metabolic disease increased during consumption for 10 wk of
a diet containing fructose-sweetened beverages that had a sub-
stantially lower GI (GI: 38–45) than did the diet consumed before
the study began (GI: 60), and during the baseline period (GI: 64),
and that resulted in the expected lowering of postprandial glucose
and insulin responses. In contrast, metabolic disease risk factors
remained unchanged during consumption for 10 wk of a diet
containing glucose-sweetened beverages that had a substantially
higher GI (GI: 81–83) than did the diet consumed before the study
began (GI: 59), and during the baseline period (GI: 64), and that
induced the expected increase in postprandial glucose and insulin
responses.
In a recent review, it was concluded that for healthy and/or
overweight subjects the importance of low-GI diets in relation to
components of the metabolic syndrome has not been established,
mainly because the diets frequently used in intervention studies
not only have different GIs but also have different fiber, protein,
and/or fat contents (43). Clearly, fructose needs to be added to
this list of potentially confounding dietary components. The
importance of this is illustrated in a recent investigation of the
relation between GI, GL, fructose, and insulin resistance in 668
nondiabetic persons. A direct association was found between
fructose intake and insulin resistance, whereas the association
between GL and insulin resistance disappeared when the model
was adjusted for fructose intake (44). It has been suggested that
a fructose index would be more relevant to cardiovascular disease
risk than is the GI (45).
A recent meta-analyses of observational studies investigating
GI and disease risk reported that low-GI diets are independently
associated with a reduced risk of coronary heart disease and
type 2 diabetes (37). The nutritional factors included in the
statistical model were alcohol, fiber, and dietary supplements, but
not fructose (37). A recent meta-analysis of intervention studies
investigating GI and markers of health concluded that con-
sumption of low-GI diets is followed by favorable changes in the
health markers (28). Again, the confounding effects of fiber were
included, but those of fructose were not (28). The biochemical
risk factors that were shown by a meta-analysis of the in-
tervention studies to be positively and independently affected by
low-GI diets were fasting blood glucose and insulin concen-
trations, insulin sensitivity, and fasting fructosamine concen-
trations (28). As we previously reported, consumption of fructose
(the diet with the lowest GI) significantly increased fasting blood
glucose concentrations and decreased insulin sensitivity com-
pared with consumption of glucose (the high-GI diet) (12).
Glycated albumin concentrations decreased significantly in
subjects who consumed fructose compared with subjects who
consumed glucose. This finding indicated that, whereas this
outcome reflected the differential glucose exposure in these
subjects, it did not accurately reflect the changes in several risk
factors for metabolic disease.
It is important to note that this study was not designed to
investigate the effects of sugar-sweetened beverage consumption
as they are commonly consumed in this country, both with re-
gard to the amount of sugar consumed and the types of sugars
consumed. Self-reported intake data suggest that only 13% of the
US population consumes 25% of energy from added sugars
(46). Furthermore, sugar-sweetened beverages are not sweet-
ened with pure glucose or pure fructose, but rather with HFCS
(55% fructose, 45% glucose) and sucrose (50% fructose, 50%
glucose). However, the current investigation of the effects of
consuming glucose- and fructose-sweetened beverages allows
for differentiation between the effects of increased glucose and
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insulin excursions and those of unregulated hepatic metabolism
of fructose, which cannot be accomplished when beverages
sweetened with HFCS or sucrose are consumed. The glucose
component of these sugars results in increased postprandial
glucose and insulin excursions, and the fructose component may
lead to unregulated hepatic lipid production. Thus, it is not pos-
sible in most diet intervention studies involving HFCS or sucrose
to determine whether the effects are mediated via changes in
glucose and insulin excursions or are a consequence of hepatic
fructose metabolism. However, a limitation of the current study
was that it did not address the possibility that there is a synergistic
relation between increased glucose and insulin excursions and
unregulated hepatic fructose metabolism, which occurs when
fructose and glucose are consumed in combination.
In conclusion, the results of this study provide strong evidence
that increased circulating glucose and insulin excursions (GI) are
not associated with the adverse effects of fructose-sweetened
beverage consumption for 10 wk by older overweight and obese
adults. Decreasing the GI by substituting fructose for complex
carbohydrate decreased meal-associated glucose and insulin
excursions and significantly increased several risk factors for
metabolic disease. Increasing the GI by simply substituting glucose
for complex carbohydrate increased meal-associated glucose and
insulin excursions, but had little, if any, adverse effect on risk factors
for metabolic disease. Thus, the adverse metabolic effects asso-
ciated with consumption of sugar-sweetened beverages appear to
result primarily from the fructose component of dietary sugars,
rather than from the glucose and insulin excursion induced by the
glucose component. The results also indicate the importance of
adjusting and controlling for dietary fructose intake when in-
vestigating the effects of GI and GL on the development of met-
abolic disease.
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